EMJ Nephrology 13 [Supplement 1] 13.1 2025

In this issue

This symposium at ERA 2025 explored the evolving treatment landscape in immunoglobulin A nephropathy (IgAN) and novel, targeted therapies under clinical development. Experts reviewed updated KDIGO guidelines and treatment goals and provided case-based insights and practical strategies to maximise proteinuria reduction and optimise patient care.